Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
about
Target-selective protein S-nitrosylation by sequence motif recognitionHypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and AtherosclerosisIs the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisLipids and the endothelium: bidirectional interactionsCholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosisDiabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesCardiovascular complications of type 1 diabetes: update on the renal link.Testing the role of myeloid cell glucose flux in inflammation and atherosclerosisAdipose tissue macrophages promote myelopoiesis and monocytosis in obesityMechanisms that regulate macrophage burden in atherosclerosis.Inflammation and thrombosis in cardiovascular disease.Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease.Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.Diet-induced obesity promotes myelopoiesis in hematopoietic stem cellsHuman CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo.miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.Macrophages in atherosclerosis: a dynamic balance.Remodeling of the thoracic aorta after bone marrow cell transplantation.Regulation and consequences of monocytosisDiabetes and immunity to tuberculosis.Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA.Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseasesSGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy.Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient MiceDifferences in Hematopoietic Stem Cells Contribute to Sexually Dimorphic Inflammatory Responses to High Fat Diet-induced Obesity.Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic miceUncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award LectureMyeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear CellsMacrophage Phenotype and Function in Different Stages of Atherosclerosis.S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?Disordered haematopoiesis and athero-thrombosis.Metabolic dysfunction and adipose tissue macrophages: is there more to glean from studying the lean?: Comment on "Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function" by Moreno-Indias et al.Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.Does Elevated Glucose Promote Atherosclerosis? Pros and Cons.Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice.
P2860
Q24307415-B8B480B2-948C-42E8-B8CC-BB28F4FDA8E9Q26742064-E8F5D0F9-D62C-4798-8236-F28FD24A24EBQ26746659-C3C0C149-30CD-460F-B573-613B7EFFA66BQ26860086-39466AF0-82F0-4ADD-B2B9-91E544B8710AQ26861206-18EB408F-A64C-4642-8C08-990CB0663738Q28072462-CAC1CC37-2358-4335-9402-FEC56347417EQ28083768-A76F0781-CD3A-477B-ACC1-35F7A6996A05Q30239971-D3E856AF-50AC-420D-964D-12863150DACEQ33612986-603AB32B-BA54-46C0-BAF6-F9BB713AEE01Q33724394-036E986F-F30E-4F1D-97E0-D68501CB994FQ33761114-FCBED86C-6415-4423-B46D-0385FBC6302BQ33864069-02E6950F-C7FC-4E56-8558-6E1552C0B432Q33902481-D5AF09F9-5CB5-4BD4-A4D5-F8749E3C939FQ33975637-F5AFDF9B-916D-460D-B415-4172A02B1D43Q34080572-2A8068B0-3E60-448F-B609-DAB82320D053Q34318508-E2836229-590A-49F4-8A0A-594ABE26FE33Q34324735-A415D5F9-B89D-4945-9F6E-F6C2062939D2Q34368005-FE438A9C-DB9D-425F-A14C-341BAD04FA07Q34371163-CBE53475-8415-4231-BEC5-178CD28BC582Q34372534-2F399EA1-4DFD-4928-A295-6ADB18ED4107Q34424824-3A02D5AD-DC6D-4014-B1CC-AC7084363C8CQ34545552-7CD43947-A1CA-4898-ADAE-315B4A8E50CAQ35099739-22E3F089-C582-4114-BC58-4B3DB723645CQ35181821-67555781-FEE4-42C2-8472-296B758CC8A3Q35196985-E24F5D04-21C3-47B6-804A-C488D3FF28B6Q35653968-7B4BCB52-E60E-4310-9937-B1A0249069B9Q35860970-545F5E3F-840A-4344-BA88-235CA26F0A88Q35879028-3814CA87-2377-435D-BE16-FAAAD63E802AQ35881759-B496CA39-A4E9-41DB-BAA2-18A1BEB1A7DEQ36063184-16A37B41-1C5D-4D0E-84B3-EF2A30FBE3DAQ36079808-140B7D00-6C6D-4312-A22B-22DDC85126EBQ36261057-715337D5-13AE-4A83-936E-40F4D183AE9BQ36602809-CA4EE587-73DA-488C-BFED-7585683538E8Q36631781-506BD676-95AE-4208-A4B2-D2E63B802747Q36681493-B1CB890E-694B-4AAE-9BC8-E6AC0270E5D9Q36773876-89133F10-729B-462B-8CDD-A0C5AA9272D5Q36900829-2032BE8B-6917-4F18-97E0-E241FBD19E47Q36920492-FE46E50C-483E-4FD2-A20E-0EDE00140920Q37083092-1B9F8A92-AF8C-4122-897E-9F7201E29F89Q37134825-EE6A2FFE-CF79-4DBC-9033-DF65023A4987
P2860
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@en
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@nl
type
label
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@en
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@nl
prefLabel
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@en
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@nl
P2093
P2860
P50
P1433
P1476
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
@en
P2093
Alan R Tall
Andrew J Murphy
Ann Marie Schmidt
Bhama Ramkhelawon
Emilie Distel
Ira J Goldberg
Li-Shin Huang
Marit Westerterp
Roslynn A Stirzaker
Shiquing Yu
P2860
P304
P356
10.1016/J.CMET.2013.04.001
P577
2013-05-01T00:00:00Z